Yong Rong (HK) Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Yong Rong (HK) Asset Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,000	Closed	-$2.77M	–	20
2019 Q3	$2.77M	Hold	10,000	–	–	3.4%	6
2019 Q2	$3.13M	Buy	+10,000	New	+$3.33M	4.51%	6
2018 Q4	–	Sell	-12,000	Closed	-$4.85M	–	27
2018 Q3	$4.85M	Hold	12,000	–	–	1.82%	9
2018 Q2	$4.14M	Buy	12,000 +4,500	+60%	+$1.41M	1.92%	7
2018 Q1	$2.58M	Buy	+7,500	New	+$2.61M	1.91%	9

Other funds holding REGN

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Yong Rong (HK) Asset Management's REGN Position: Q4 2019 in Review

Yong Rong (HK) Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2019, closing a stake of 10,000 shares — an estimated $2.77M sold.

Yong Rong (HK) Asset Management first reported a position in REGN in Q1 2018 and held it in 5 quarters. The position peaked at $4.85M in Q3 2018. 703 funds tracked by Wall St. Rank hold REGN as of Q4 2019.

Yong Rong (HK) Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
Yong Rong (HK) Asset Management sold 10,000 Regeneron Pharmaceuticals shares in Q4 2019, an estimated $2.77M.
Yong Rong (HK) Asset Management first reported a position in Regeneron Pharmaceuticals in Q1 2018 and held it in 5 quarters.
Yong Rong (HK) Asset Management's Regeneron Pharmaceuticals position peaked at $4.85M in Q3 2018.
703 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2019.

Based on Yong Rong (HK) Asset Management's 13F filing for Q4 2019, filed 19 Feb 2020.